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The patient
Mr Massae (not his real name) is a forty-eight 
year old farmer who recently presented at a 
tertiary ophthalmology unit in Tanzania with 
a three-week long history of pain, purulent 
discharge, and loss of vision in the left eye. 
Several days after the onset, he had 
received treatment from his local health 
centre (chloroamphenicol drops), but his 
eye continued to get worse. At presentation, 
he had a large corneal ulcer with infiltration 
and a hypopyon. A filamentous fungus was 
cultured from microbiology specimens. He 
was treated with intensive topical antifungal 
(econazole) and anti-bacterial (ciprofloxacin) 
drops, a topical cycloplegic (atropine), and 
an oral antifungal medication (itraconazole). 
A small corneal perforation developed which 
plugged with iris and then sealed. The infection 
gradually responded to prolonged antifungal 
therapy, leaving a dense scar and small 
eccentric pupil (Figure 1, over page). Four 
years earlier, Mr Massae had lost sight in his 
right eye due to severe suppurative keratitis 
following a minor corneal abrasion from a 
maize leaf; this caused dense scarring of 
his right cornea (Figure 2, over page). 
Mr Massae is now blind.
The burden
Unfortunately, Mr Massae’s story is not 
unique. Blindness from corneal disease is a 
major ophthalmic public health problem. 
According to the most recent WHO global 
data on the causes of blindness (2002), 
‘corneal opacities’ affected 1.9 million 
people (5.1% of the total number of bind 
people). If other conditions causing 
blindness through corneal pathology are 
included, such as trachoma, vitamin A 
deficiency, ophthalmia neonatorum, and 
onchocerciasis, the number would be signif-
icantly higher. Moreover, there are probably 
many tens of millions more who are blind in 
one eye from corneal disease. 
The burden of corneal blindness on the 
individual and the wider community can be 
huge, particularly as it tends to affect people 
at a younger age than other blinding conditions 
such as cataract and glaucoma. It also 
disproportionately affects poor rural 
communities, because of the increased risk 
of eye injuries from contaminated objects 
such as plant material, limited access to 
treatment, and higher prevalence of 
communicable diseases such as trachoma 
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Corneal blindness often affects people at a young age, such as this twelve year old 
girl who is blind from vitamin a deficiency. She has had a penetrating corneal graft 
in her left eye; this has unfortunately failed. EtHIOPIa
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 Journal and onchocerciasis. Mr Massae illustrates 
the burden from corneal disease: he is 
currently unable to farm his land and provide 
food for his family.
The causes
There are many different conditions which 
can damage the structure and shape of the 
cornea leading to visual impairment and 
blindness. These include infectious, nutri-
tional, inflammatory, inherited, iatrogenic 
(doctor-caused), and degenerative conditions 
(see box opposite). Disease patterns vary in 
different environments. 
Overall, in low- and middle-
income countries, infectious 
keratitis tends to be the 
most common problem. 
However, other conditions, 
such as trachoma or 
onchocerciasis, may 
dominate in some areas.
Controlling 
corneal blindness
There are three important elements to 
addressing corneal blindness: prevention, 
treatment, and rehabilitation. In this issue of 
the Community Eye Health Journal, you will 
find articles addressing aspects of each of 
these. In Mr Massae’s case, we can see how 
all three elements are 
needed, as well as some of 
the challenges in their 
implementation. 
Prevention
Some blinding corneal 
conditions are very difficult 
to treat once established; 
however, they can be 
prevented by specific 
public health interventions 
(see page 36).
• Xerophthalmia, which 
is caused by vitamin A 
deficiency and 
sometimes precipitated 
by measles, accounts for 
more than half the new 
cases of childhood 
blindness each year. In 
addition to blindness, 
these young children are 
at increased risk of 
death. Prevention is key: 
vitamin A 
supplementation, 
measles vaccination, 
and nutritional advice 
have led to a marked 
reduction in this 
condition.
• trachoma, caused by 
recurrent infection with 
Chlamydia trachomatis, 
causes blinding corneal 
opacification through the 
traumatic effect of entropion/trichiasis and 
possibly secondary bacterial infection. 
Once established, trachomatous corneal 
opacification is difficult to treat: the results 
of corneal grafting are often disappointing, 
in part due to a dry and damaged ocular 
surface. Blinding trachoma can be 
prevented through the full implementation 
of the SAFE Strategy (Surgery for trichiasis, 
Antibiotics for infection, Facial cleanliness 
and Environmental improvement to control 
transmission). 
• Onchocerciasis (river blindness) leads 
to blindness through an 
inflammatory response to 
the microfilaria of 
Onchocerca volvulus in the 
retina and the cornea. 
Control programmes have 
been very effective in 
preventing blindness through 
the mass distribution of 
ivermectin and measures to 
control the Simulium fly.
• traumatic corneal abrasion is a common 
event and is the major risk factor for 
microbial keratitis in low- and middle-
income countries. Simple topical antibiotic 
prophylaxis for a few days while the 
epithelium heals can protect the eye from 
developing potentially blinding infection. Mr 
Massae lost the sight in his right eye after 
‘The results of 
corneal grafting 
after blinding 
trachoma can be 
disappointing’
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trachoma is one of the most common causes of corneal 
blindness. Improvement in water supply facilitates facial 
cleanliness, one of the four components of the SaFE 
strategy for trachoma control. PaKIStan
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is possible that early antibiotic prophylaxis 
could have prevented this.
Treatment
In most low- and middle-income countries, 
microbial keratitis is the most common 
acute blinding corneal problem requiring 
treatment. There is often a history of minor 
trauma. If appropriate antibiotic prophylaxis 
is not started soon after the injury, infection 
can become established. In temperate 
climates, most infections are bacterial. In 
contrast, in tropical regions, fungal keratitis 
is more frequent and may account for about 
half the cases.
The treatment of microbial keratitis is 
discussed in detail in the articles on pages 
39–41.
Several problems make it difficult to 
deliver effective treatment for microbial 
keratitis in a low- and middle-income 
country setting. These problems need to be 
addressed by eye care programmes in order 
to reduce the risk of blindness from 
microbial keratitis and include:
• Delayed presentation. There may be 
many days or even weeks between the 
onset of symptoms and the presentation 
of the patient at an appropriate health 
facility. This delay is often catastrophic, 
allowing time for deep-seated infection to 
develop and extensive corneal damage to 
occur. Timely presentation may be 
promoted through health education and 
training of staff at primary health facilities 
to recognise and refer patients with 
established microbial keratitis. 
• traditional medication. This may 
sometimes be used by the patient before 
presentation and can make the problem 
more severe through the harmful effect of 
toxic compounds and infection with 
additional microorganisms.
• Microbiology. It may not be possible to 
obtain a microbiological diagnosis or 
information about the sensitivity of the 
organism. This can lead to the use of 
ineffective treatment and is particularly a 
problem when fungal keratitis is missed. 
The development of a basic microbiological 
service with gram staining of slides can 
help to identify some cases of fungal 
infection. Blindness control programmes 
need to know which organisms commonly 
cause microbial keratitis in their 
population as well as their pattern of 
antibiotic resistance so that appropriate 
drugs can be supplied to health facilities.
• Inadequate treatment. The patient may 
not receive effective treatment. This can 
occur for several reasons: appropriate 
antibacterial or antifungal drops may not 
be available, the microorganism may be 
resistant to the medication, or the drops 
may not be given with sufficient intensity. 
Some of these problems can be overcome 
with the development of locally 
appropriate treatment protocols.
Mr Massae’s case illustrates some of these 
issues. It was several weeks before he 
reached an ophthalmology unit and 
received treatment, which contributed to 
the severity of the case. It was very helpful in 
his management to have a microbiological 
diagnosis as it guided the choice and 
duration of treatment. 
Rehabilitation
Mr Massae is now blind. However, his left 
eye has perception of light and has the 
potential to see better; to be rehabilitated. 
It may be possible to offer him some 
improvement in vision with a pupilloplasty. 
In addition, as the left corneal scar does not 
involve the superior cornea, a rotational 
auto-graft, in which an eccentric corneal 
button is cut and rotated to bring the clear 
superior cornea into the centre, may help. 
However, a penetrating corneal graft (trans-
plant) would probably offer him the best 
quality of vision. 
In many low- and middle-income 
countries, options for visual rehabilitation 
from corneal disease are limited as it 
usually requires the services of an ophthal-
mologist with sub-specialty training in 
corneal surgery, equipped to perform the 
surgery and with access to donated corneas 
from an eye bank.
In this issue, there is an article on corneal 
grafting (page 44) which discusses the 
indications for corneal grafting, the 
outcomes for different conditions, and 
some of the potential complications. The 
following article focuses on eye banking 
(page 46) and addresses some of the 
specific challenges involved in running an 
eye bank service and finding donors.
Without rehabilitation services, Mr 
Massae and several million people like 
him are destined to a life without sight. 
Without the implementation of the 
public health and treatment interventions 
outlined above, many more will be at risk 
of joining them.
Infectious
• Bacterial keratitis
• Fungal keratitis
• Viral keratitis 
• Trachoma
• Onchocerciasis
• Leprosy
• Ophthalmia neonatorum
Nutritional
• Vitamin A deficiency (xerophthalmia)
Inflammatory
• Mooren’s ulcer
• Steven’s Johnson Syndrome
Inherited
• Corneal stromal dystophies
• Fuch’s endothelial dystrophy
Degenerative
• Keratoconus
Trauma
• Corneal abrasion predisposing to 
microbial keratitis
• Penetrating trauma
• Chemical injury
Doctor-caused (iatrogenic)
• Pseudophakic bullous keratopathy
Causes of corneal blindness
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Figure 1. Mr Massae’s left eye, after several weeks of treatment Figure 2. Mr Massae’s right eye
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